ACM Research’s Hui Wang plans 65K-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACM Research, Inc. (ACMR) officer, director and 10% stockholder Hui Wang reported an intended sale of 65,000 common shares, with an approximate sale date of November 18, 2026, and an aggregate market value of $2,824,614. The notice names Morgan Stanley Smith Barney LLC as broker and NASDAQ as the exchange. It lists a Rule 10b5-1 plan adoption date of June 5, 2026.
Wang reported acquiring 65,000 shares from the issuer through a cash stock-option exercise on November 18, 2026. The notice lists 65,019,350 common shares outstanding. It also lists prior sales of 65,000 shares on November 17, 2026, 70,000 on September 9, 2026, and 70,000 on September 8, 2026, with gross proceeds of $2,825,160, $5,221,482, and $5,408,522, respectively.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Stock Option Exercise financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.